Public Calendar: November 3-9, 2024
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs
Event Date: 11/04/2024
Location: Bethesda, MD
Subject: FDA's 2025 and 2026 Program and Funding
FDA Participant/Group: STACY MATHEW;
Non FDA Participant/Group: Several board members from Alliance for a Stronger FDA
Event Date: 11/06/2024
Location: Silver Spring, MD
Subject: FDA Digital Transformation Symposium; Panelist: Fireside Chat: Modernizing the FDA - Leveraging IT Strategy for a Digital Future
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and other registered attendees
Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner
No Significant Event
Official Name: Jim Jones, Deputy Commissioner for Human Foods
Event Date: 11/07/2024
Location: Virtual
Subject: National Retail Federation Food Safety Task Force Meeting; Keynote: Human Foods Program Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the National Retail Federation
Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 11/07/2024
Location: Virtual
Subject: 16th Annual Sentinel Initiative Public Workshop; Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 11/06/2024
Location: Virtual
Subject: Society for Immunotherapy of Cancer 2024 - Society for Immunotherapy of Cancer Biotech Regulatory Roundtable; Fireside Chat and Q&A
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees
Event Date: 11/07/2024
Location: Virtual
Subject: 2024 Global Science Summit - Angelman Syndrome Biomarker and Outcome Measures Pre-Competitive Consortium; Speaker: Development of Gene Therapies for Rare Pediatric Disorders
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees
Event Date: 11/08/2024
Location: Virtual
Subject: Critical Path Institute/FDA 2024 Annual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the Critical Path Institute
Event Date: 11/08/2024
Location: Virtual
Subject: Plasma Protein Therapeutics Association/FDA Liaison Meeting
FDA Participant/Group: RACHAEL ANATOL; CELIA SILVERMAN; SHERYL LARD WHITEFORD; ANNE EDER; MELISSA MENDOZA; ORIEJI ILLOH; BASIL GOLDING;
Non FDA Participant/Group: Representatives of the Plasma Protein Therapeutics Association
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 11/05/2024
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: MARINA MOSES; OWEN FARIS; KEISHA THOMAS; ROSS SEGAN; ERIN KEITH; MICHELLE TARVER;
Non FDA Participant/Group: Brian Schultz, Roseanne Leaupepe, Zaheer Khan (Fisher and Paykel)
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event